ES2223581T3 - Agonistas beta para el tratamiento de la endometriosis o de la infertilidad o mejora de la fertilidad. - Google Patents

Agonistas beta para el tratamiento de la endometriosis o de la infertilidad o mejora de la fertilidad.

Info

Publication number
ES2223581T3
ES2223581T3 ES00964272T ES00964272T ES2223581T3 ES 2223581 T3 ES2223581 T3 ES 2223581T3 ES 00964272 T ES00964272 T ES 00964272T ES 00964272 T ES00964272 T ES 00964272T ES 2223581 T3 ES2223581 T3 ES 2223581T3
Authority
ES
Spain
Prior art keywords
use according
endometriosis
terbutaline
adrenergic
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00964272T
Other languages
English (en)
Spanish (es)
Inventor
William J. Bologna
Dominique De Ziegler
Howard L. Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia Laboratories Bermuda Ltd
Original Assignee
Columbia Laboratories Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd
Application granted granted Critical
Publication of ES2223581T3 publication Critical patent/ES2223581T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES00964272T 1999-10-05 2000-10-04 Agonistas beta para el tratamiento de la endometriosis o de la infertilidad o mejora de la fertilidad. Expired - Lifetime ES2223581T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US157754P 1999-10-05
US66838400A 2000-09-25 2000-09-25
US668384 2000-09-25

Publications (1)

Publication Number Publication Date
ES2223581T3 true ES2223581T3 (es) 2005-03-01

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00964272T Expired - Lifetime ES2223581T3 (es) 1999-10-05 2000-10-04 Agonistas beta para el tratamiento de la endometriosis o de la infertilidad o mejora de la fertilidad.

Country Status (28)

Country Link
EP (1) EP1220667B1 (enExample)
JP (2) JP2003510354A (enExample)
KR (1) KR100738724B1 (enExample)
CN (1) CN1218694C (enExample)
AR (1) AR028487A1 (enExample)
AT (1) ATE271860T1 (enExample)
AU (1) AU780736B2 (enExample)
BR (1) BR0014548A (enExample)
CA (1) CA2385974C (enExample)
CO (1) CO5251423A1 (enExample)
DE (1) DE60012554T2 (enExample)
DK (1) DK1220667T3 (enExample)
ES (1) ES2223581T3 (enExample)
GE (1) GEP20043313B (enExample)
HK (1) HK1044120B (enExample)
HU (1) HU225990B1 (enExample)
IL (2) IL148784A0 (enExample)
MA (1) MA25501A1 (enExample)
MX (1) MXPA02003453A (enExample)
MY (1) MY129518A (enExample)
NO (1) NO329663B1 (enExample)
NZ (1) NZ518429A (enExample)
PE (1) PE20010742A1 (enExample)
PT (1) PT1220667E (enExample)
TR (1) TR200200899T2 (enExample)
TW (1) TWI280877B (enExample)
UA (1) UA74168C2 (enExample)
WO (1) WO2001024788A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN107260745A (zh) * 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
US10328022B2 (en) 2012-05-31 2019-06-25 Repros Therapeutics Inc. Formulations and methods for vaginal delivery of antiprogestins
HK1211852A1 (en) 2012-11-02 2016-06-03 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
AU5068090A (en) * 1989-03-07 1990-09-13 Adeza Biomedical Corporation Endometriosis diagnosis methods and reagents
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
NZ518429A (en) 2004-02-27
CA2385974A1 (en) 2001-04-12
WO2001024788A3 (en) 2001-12-06
NO329663B1 (no) 2010-11-29
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
EP1220667A2 (en) 2002-07-10
PT1220667E (pt) 2004-11-30
ATE271860T1 (de) 2004-08-15
CN1218694C (zh) 2005-09-14
UA74168C2 (uk) 2005-11-15
JP2003510354A (ja) 2003-03-18
DK1220667T3 (da) 2004-12-06
MY129518A (en) 2007-04-30
DE60012554D1 (de) 2004-09-02
TWI280877B (en) 2007-05-11
HUP0203050A3 (en) 2006-02-28
AU780736B2 (en) 2005-04-14
DE60012554T2 (de) 2005-11-24
CA2385974C (en) 2010-01-26
GEP20043313B (en) 2004-03-10
IL148784A0 (en) 2002-09-12
TR200200899T2 (tr) 2002-07-22
AR028487A1 (es) 2003-05-14
HU225990B1 (en) 2008-02-28
IL148784A (en) 2006-12-31
CO5251423A1 (es) 2003-02-28
KR100738724B1 (ko) 2007-07-12
BR0014548A (pt) 2002-06-04
NO20021591L (no) 2002-05-28
EP1220667B1 (en) 2004-07-28
CN1377264A (zh) 2002-10-30
PE20010742A1 (es) 2001-07-19
MA25501A1 (fr) 2002-07-01
KR20020062285A (ko) 2002-07-25
HK1044120B (en) 2004-12-17
NO20021591D0 (no) 2002-04-04
WO2001024788A2 (en) 2001-04-12
MXPA02003453A (es) 2002-08-20
HUP0203050A2 (hu) 2003-02-28
HK1044120A1 (en) 2002-10-11

Similar Documents

Publication Publication Date Title
ES2210813T3 (es) Composicion farmaceutica destinada para el tratamiento de las disminorreas y del parto prematuro.
JP2010018639A (ja) 子宮内膜炎または不妊症の処置および妊孕性の改善
US20110053845A1 (en) Localized vaginal delivery without detrimental blood levels
KR100908161B1 (ko) 응급피임용 투약방법 및 약제학적 조성물
CN101917848B (zh) 用于治疗子宫收缩过强病症的s-烷基异硫脲衍生物
CN113347975B (zh) 用于治疗侵蚀性手骨关节炎的孟鲁司特
RU2310474C2 (ru) Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
US12011423B2 (en) S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
TW200406223A (en) Extended, controlled-release pharmaceutical compositions using charged polymers
KR20060123329A (ko) 월경 곤란증의 예방 및/또는 치료제
CN104510751B (zh) 一种治疗妇女痛经的中药单体组合物及其用途
HK1055896A (en) A pharmaceutical composition for treating dysmenorrhea and premature labor